Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Robert Thomas Freeman Sells 6,744 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Robert Thomas Freeman sold 6,744 shares of Alignment Healthcare stock in a transaction on Thursday, March 27th. The stock was sold at an average price of $17.89, for a total value of $120,650.16. Following the completion of the sale, the chief financial officer now directly owns 1,464,419 shares of the company’s stock, valued at approximately $26,198,455.91. The trade was a 0.46 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link.

Robert Thomas Freeman also recently made the following trade(s):

• On Tuesday, March 18th, Robert Thomas Freeman sold 13,815 shares of Alignment Healthcare stock. The shares were sold at an average price of $16.89, for a total value of $233,335.35.
• On Wednesday, March 12th, Robert Thomas Freeman sold 14,692 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.43, for a total value of $226,697.56.
• On Thursday, March 6th, Robert Thomas Freeman sold 218,295 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.53, for a total transaction of $3,390,121.35.
• On Tuesday, March 4th, Robert Thomas Freeman sold 250,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.58, for a total transaction of $3,895,000.00.

Alignment Healthcare Trading Up 0.9 %

Shares of NASDAQ:ALHC opened at $18.30 on Friday. The stock has a 50 day moving average of $15.28 and a 200 day moving average of $12.97. The company has a market cap of $3.51 billion, a PE ratio of -23.77 and a beta of 1.49. Alignment Healthcare, Inc. has a 12-month low of $4.46 and a 12-month high of $18.44. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82.

Hedge Funds Weigh In On Alignment Healthcare

Several large investors have recently added to or reduced their stakes in ALHC. Wellington Management Group LLP increased its stake in shares of Alignment Healthcare by 77.9% in the fourth quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company’s stock worth $83,683,000 after purchasing an additional 3,257,630 shares in the last quarter. Mackenzie Financial Corp boosted its holdings in Alignment Healthcare by 149.8% in the 4th quarter. Mackenzie Financial Corp now owns 85,175 shares of the company’s stock worth $958,000 after buying an additional 51,084 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Alignment Healthcare by 15.9% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 263,203 shares of the company’s stock worth $2,961,000 after buying an additional 36,151 shares in the last quarter. Voloridge Investment Management LLC bought a new stake in Alignment Healthcare during the fourth quarter valued at about $189,000. Finally, Squarepoint Ops LLC lifted its position in shares of Alignment Healthcare by 414.6% in the fourth quarter. Squarepoint Ops LLC now owns 198,309 shares of the company’s stock valued at $2,231,000 after acquiring an additional 159,774 shares in the last quarter. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the stock. Bank of America lifted their target price on shares of Alignment Healthcare from $15.50 to $18.50 and gave the stock a “buy” rating in a research report on Tuesday, March 4th. Stifel Nicolaus upped their price objective on Alignment Healthcare from $16.00 to $18.00 and gave the company a “buy” rating in a research report on Friday, February 28th. William Blair reissued an “outperform” rating on shares of Alignment Healthcare in a report on Friday, February 28th. JPMorgan Chase & Co. boosted their price target on Alignment Healthcare from $14.00 to $17.00 and gave the company a “neutral” rating in a research note on Thursday, March 6th. Finally, Stephens reiterated an “overweight” rating and issued a $17.00 price objective on shares of Alignment Healthcare in a research note on Monday, February 24th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, Alignment Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $14.83.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.